Lactulose vs Lactobacillus acidophilus for patients with chronic kidney disease: A randomized controlled trial

doi:10.5527/wjn.120870

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

(0)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Nephrol. Sep 25, 2026; 15(3): 120870
Published online Sep 25, 2026. doi: 10.5527/wjn.120870

Open in New Tab Full Size Figure Download Figure

Figure 1 CONSORT flowchart of patients. Patients were randomly allocated to the therapeutic groups: Lactulose, Lactobacillus acidophilus, or no therapy. LA: Lactobacillus acidophilus.

Open in New Tab Full Size Figure Download Figure

Figure 2 Delta change after three months in the studied groups. A: Delta change in urea level after three months in the studied groups; B: Delta change in creatinine level after three months in the studied groups. LA: Lactobacillus acidophilus.

Citation: Mubarak AS, Elshazly A, Mokhtar A, Gadelkareem RA, Azoz NM. Lactulose vs Lactobacillus acidophilus for patients with chronic kidney disease: A randomized controlled trial. World J Nephrol 2026; 15(3): 120870
URL: https://www.wjgnet.com/2220-6124/full/v15/i3/120870.htm
DOI: https://dx.doi.org/10.5527/wjn.120870

Mubarak AS, Elshazly A, Mokhtar A, Gadelkareem RA, Azoz NM. Lactulose vs Lactobacillus acidophilus for patients with chronic kidney disease: A randomized controlled trial. World J Nephrol 2026; 15(3): 120870 [DOI: 10.5527/wjn.120870]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.